Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Basal Ganglia Lesions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Large-scale testing (Phase 3)Study completedNCT00244387
What this trial is testing

Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa

Who this might be right for
Parkinson Disease, Idiopathic
UCB Pharma 506
Large-scale testing (Phase 3)Study completedNCT00243971
What this trial is testing

A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma
Testing effectiveness (Phase 2)Study completedNCT00089622
What this trial is testing

Lisuride Patch to Treat Parkinson's Disease

Who this might be right for
Parkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 40
Early research (Phase 1)Study completedNCT02728947
What this trial is testing

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Luye Pharma Group Ltd. 28
Not applicableStudy completedNCT01159691
What this trial is testing

Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal Patch

Who this might be right for
Idiopathic Parkinson's Disease
UCB Pharma GmbH 76
Not applicableStudy completedNCT06389903
What this trial is testing

Subthalamic Nucleus Stimulation Electrode and Psychiatric Lesion Effects in Parkinson's Disease

Who this might be right for
Parkinson Disease
Centre Hospitalier du Rouvray 15
Post-approval studies (Phase 4)Study completedNCT00988117
What this trial is testing

The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems

Who this might be right for
Parkinsons Disease With DementiaParkinsons Disease With Mild to Moderate Memory and/or Thinking Problems
University of California, San Francisco 15
Not applicableStudy completedNCT03438123
What this trial is testing

Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera

Who this might be right for
DementiaParkinson DiseasePulmonary Hypertension+7 more
Spectrum Dynamics 140
Not applicableNot Yet RecruitingNCT07015346
What this trial is testing

Adhesion and Safety of Rotigexole Compared to Neupro®

Who this might be right for
Idiopathic Parkinson Disease
Eva Pharma 40
Early research (Phase 1)Study completedNCT01338896
What this trial is testing

Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations

Who this might be right for
Parkinson's Disease
UCB Pharma 56
Not applicableUnknownNCT02052947
What this trial is testing

Co-LEsions in Alzheimer Disease and Related Disorders

Who this might be right for
Alzheimer's DiseaseCerebrovascular DiseaseLewy Body Disease
Hospices Civils de Lyon 214
Not applicableStudy completedNCT00599339
What this trial is testing

Transdermal Rotigotine User Surveillance Study

Who this might be right for
Idiopathic Parkinson Disease
UCB Pharma 2,195